Radiation Therapy Utilization And Prostate Cancer
Published on Feb 04 2010, in the categories: Uncategorized
Radiation therapy utilization and prostate cancer are two concepts that go hand in hand. The combination of radiotherapy with standard medicine treatment reduces by half the number of fatalities caused by advanced forms of prostate cancer and should become the new standard therapy accepted world wide, according to several Swedish experts.
The study has been published in the Lancet Oncology magazine and carried on 800 patients with prostate cancer. The study showed that 24% of the patients who received standard treatment died after 10 years, compared to the 12% of patient who received radiotherapy.
The combination of radiation therapy utilization and prostate cancer, added with standard medication, cannot produce side effects, according to Swedish experts. "The quality of life and side effects are situated at an acceptable level. This is why we suggest that the endocrine treatment combined with radiotherapy become the new treatment standard for our patients ", said Anders Widmark at the Umea University.
Prostate cancer occupies second place in the top of deadly types of cancer among men, making over 221.000 de victims worldwide each year. Almost 679.000 new cases are discovered each year. Prostate cancer is easy to treat, through surgery or radiotherapy, if it is discovered in time. For the cases in which prostate cancer spread in the organism, there are several drugs to be prescribed. These drugs interfere with the hormones that support the cancer cells.
In the United States of America, using radiotherapy combined with medication is already a treatment standard, according to Howard Sandler, the chief of radiology- oncology section of Cedars Sinai Hospital in Los Angeles, and the spokesman of American Society of Clinical Oncology. He said that medical clinics in Europe are not using radiotherapy in their standard treatments. A decrease of almost 50% of the deaths cause by prostate cancer definitely represents an evident medical benefit, according to Sandler.
For men diagnosed with advanced prostate cancer, combining radiotherapy with medication and androgen hormones reduces the risk of death with almost 50%, according to the results of a study released in September 22, 2008 at the Annual Meeting of the American Society of Clinical Oncology and Radiology in Boston.
Advanced prostate cancer is the cancer which grows on the edge of the prostate or it covers it by invading the surrounding woven, but it did not metastasize in regional ganglion or in any other organs. In this study, anti androgen hormones is used to treat cancer by blocking the stimulation effect of testosterone in prostate cancer cells and this way it slows down the growth of the tumor. Radiotherapy is represented by daily sessions of irradiation applied on the prostate. The study, which was carried on 800 patients, showed that 18% of those who only had hormonal treatment died of prostate cancer, compared to 9% of those who received both types of therapy.
The study has been published in the Lancet Oncology magazine and carried on 800 patients with prostate cancer. The study showed that 24% of the patients who received standard treatment died after 10 years, compared to the 12% of patient who received radiotherapy.
The combination of radiation therapy utilization and prostate cancer, added with standard medication, cannot produce side effects, according to Swedish experts. "The quality of life and side effects are situated at an acceptable level. This is why we suggest that the endocrine treatment combined with radiotherapy become the new treatment standard for our patients ", said Anders Widmark at the Umea University.
Prostate cancer occupies second place in the top of deadly types of cancer among men, making over 221.000 de victims worldwide each year. Almost 679.000 new cases are discovered each year. Prostate cancer is easy to treat, through surgery or radiotherapy, if it is discovered in time. For the cases in which prostate cancer spread in the organism, there are several drugs to be prescribed. These drugs interfere with the hormones that support the cancer cells.
In the United States of America, using radiotherapy combined with medication is already a treatment standard, according to Howard Sandler, the chief of radiology- oncology section of Cedars Sinai Hospital in Los Angeles, and the spokesman of American Society of Clinical Oncology. He said that medical clinics in Europe are not using radiotherapy in their standard treatments. A decrease of almost 50% of the deaths cause by prostate cancer definitely represents an evident medical benefit, according to Sandler.
For men diagnosed with advanced prostate cancer, combining radiotherapy with medication and androgen hormones reduces the risk of death with almost 50%, according to the results of a study released in September 22, 2008 at the Annual Meeting of the American Society of Clinical Oncology and Radiology in Boston.
Advanced prostate cancer is the cancer which grows on the edge of the prostate or it covers it by invading the surrounding woven, but it did not metastasize in regional ganglion or in any other organs. In this study, anti androgen hormones is used to treat cancer by blocking the stimulation effect of testosterone in prostate cancer cells and this way it slows down the growth of the tumor. Radiotherapy is represented by daily sessions of irradiation applied on the prostate. The study, which was carried on 800 patients, showed that 18% of those who only had hormonal treatment died of prostate cancer, compared to 9% of those who received both types of therapy.
If you liked this post, subscribe to our blog by filling your e-mail address below:
Want to add something? Post your comments